Re: Patients' Preferences for Adjuvant Sorafenib after Resection of Renal Cell Carcinoma in the SORCE Trial: What Makes it Worthwhile?
| Image |  |
|---|---|
| Description | scientific article published on 30 May 2018 |
| Author/s |
author: M. Pilar Laguna |
| Publication date | May 30, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |